Many people have occasional signs and symptoms of irritable bowel syndrome, but you're more likely to
have IBS if you:
- Are young. IBS tends to occur in people under age 45.
- Are female. Overall, about twice as many women as men have the condition.
Have a family history of IBS. Studies suggest that people who have a family
member with IBS may be at increased risk of the condition.
Have a mental health problem. Anxiety, depression, a personality disorder and a
history of childhood sexual abuse are risk factors. For women, domestic abuse may be a risk
factor as well.
The influence of family history on IBS risk may be related to genes, shared factors in a family's
environment or both.
July 31, 2014
Irritable bowel syndrome. The National Digestive Diseases Information Clearinghouse.
http://www.digestive.niddk.nih.gov/ddiseases/pubs/ibs/. Accessed April 23, 2014.
Camilleri M. Peripheral mechanisms in irritable bowel syndrome. New England Journal of
Ferri FF. Ferri's Clinical Advisor 2014: 5 Books in 1. Philadelphia, Pa.: Mosby
Elsevier; 2014. https://www.clinicalkey.com. Accessed April 23, 2014.
Wald A. Diagnosis of irritable bowel syndrome. http://www.uptodate.com/home. Accessed
April 23, 2014.
Wald A. Pathophysiology of irritable bowel syndrome. http://www.uptodate.com/home.
Accessed April 23, 2014.
Wald A. Treatment of irritable bowel syndrome. http://www.uptodate.com/home. Accessed
April 23, 2014.
Rome III diagnostic criteria for functional gastrointestinal disorders. Rome Foundation.
http://www.romecriteria.org/criteria/. Accessed April 23, 2014.
Cristofori F, et al. Increased prevalence of celiac disease among pediatric patients
with irritable bowel syndrome: A 6-year prospective cohort study. Journal of the
American Medical Association Pediatrics. In press. Accessed May 5, 2014.
Brandt LJ, et al. An evidence-based systematic review on the management of irritable
bowel syndrome. American Journal of Gastroenterology. 2009;104(suppl):1.
AskMayoExpert. IBS. Rochester, Minn.: Mayo Foundation for Medical Education and
Lakhan SE, et al. Mindfulness-based therapies in the treatment of somatization
disorders: A systematic review and meta-analysis. PLoS One. 2013;8:e71834.
Muir JG, et al.The low FODMAP diet for treatment of irritable bowel syndrome and other
gastrointestinal disorders. Gastroenterology & Hepatology. 2013;9:450.
Vazquez-Roque MI, et al. A controlled trial of gluten-free diet in patients with
irritable bowel syndrome-diarrhea: Effects on bowel frequency and intestinal function.
Hungin APS, et al. Systematic review: Probiotics in the management of lower
gastrointestinal symptoms in clinical practice — an evidence-based international
guide. Alimentary Pharmacology and Therapeutics. 2013;38:864.
Relaxation techniques for health: An introduction. National Center for Complementary and
Alternative Medicine. http://nccam.nih.gov/health/stress/relaxation.htm. Accessed May 6,
Herbs at a glance: Peppermint oil. National Center for Complementary and Alternative
Medicine. http://nccam.nih.gov/health/peppermintoil. Accessed May 6, 2014.
Manheimer E, et al. Acupuncture for treatment of irritable bowel syndrome. Cochrane
Database of Systematic Reviews.
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005111.pub3/abstract. Accessed May
Lindfors P, et al. Effects of gut-directed hypnotherapy on IBS in different clinical
settings — results from two randomized, controlled trials. American Journal of
McKenzie YA, et al. British Dietetic Association evidence-based guidelines for the
dietary management of irritable bowel syndrome in adults. Journal of Human Nutrition and
Chao G, et al. Effectiveness of acupuncture to treat irritable bowel syndrome: A
meta-analysis. World Journal of Gastroenterology. 2014;20:1871.
Rey E, et al. Chronic constipation, irritable bowel syndrome with constipation and
constipation with pain/discomfort: Similarities and differences. American Journal of
Gastroenterology. In press. Accessed March 4, 2014.
Camilleri M. Current and future pharmacological treatments for diarrhea-predominant
irritable bowel syndrome. Expert Opinion on Pharmacotherapy. 2013;14:1151.
- Golden AK. Decision Support System. Mayo Clinic, Rochester, Minn. April 24, 2014.
U.S. News best hospitals 2013-2014. U.S. News & World Report.
Accessed April 24, 2014.
- Picco MF (expert opinion). Mayo Clinic, Jacksonville, Fla. May 14, 2014.
Ottillinger B, et al. STW 5 (Iberogast) — A safe and effective standard in the
treatment of functional gastrointestinal disorders. Wiener Medizinische Wochenschrift.
Dai C, et al. Probiotics and irritable bowel syndrome. World Journal of
Sisson G, et al. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo
in the irritable bowel syndrome — a 12 week double-blind study. Alimentary
Pharmacology and Therapeutics. In press. Accessed May 18, 2014.
- Bauer BA (expert opinion). May Clinic, Rochester, Minn. May 16, 2014.